<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39398055</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in China.</ArticleTitle><Pagination><StartPage>e38404</StartPage><MedlinePgn>e38404</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38404</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2024.e38404</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Acute angle-closure glaucoma (AACG) is a major cause of irreversible and severe visual function loss. Robust rise in AACG was observed in the ophthalmic outpatient clinics concomitant with the outbreak of COVID-19 infection in China after the relaxing of "zero-COVID policy" in early December 2022. Here we compared the demographic and clinical proﬁles of patients with AACG before, during and after the COVID-19 outbreak. Underlying mechanisms were tentatively investigated.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This is a retrospective comparative study. Consecutive cases with newly diagnosed AACGs in a tertiary eye hospital were retrospectively collected during December 17, 2022 to January 8, 2023. Data from the same period in 2018-2019 and 2019-2020, 2020-2021 and 2021-2022, and 2023-2024 were collected as pre-pandemic, pandemic-control, and post-pandemic control, respectively. For the patients in 2022-2023 outbreak group, COVID-19 infection was confirmed by reversed transcriptase-polymerase chain reaction or antibody test for severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) from nasopharyngeal swabs. Ocular parameters, serum electrolytes and coagulative parameters were compared between COVID-19 positive and negative AACGs in observational group. SARS-CoV-2 nucleic acid in the aqueous humor was detected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 106 AACG cases were diagnosed during the outbreak period in 2022-2023. In contrast, 18 (in 2018-2019) and 22 (in 2019-2020) cases were included during pre-pandemic period, and 21 (in 2023-2024) during the post-pandemic period. Only 13 and 4 newly onset AACG were included in 2020-2021 and 2021-2022 during the pandemic-control period, respectively. Younger age and higher proportion of bilateral involvement were detected in COVID-19 outbreak group than that of other groups (p = 0.034 and p = 0.080). Sixty-eight (64.2 %) patients in the outbreak group had a confirmed COVID-19 infection. Intervals between infection and AACG attack was 52 ± 85h (0-15d). Fifty-three patients (77.9 %) reported the applications of ibuprofen or other antipyretic medications and 25 (36.8 %) reported large volume water intake before AACG attack. COVID-19-positive AACG patients had higher level of D-dimer than their negative counterparts (1.13 ± 2.60 mg/L vs. 0.46 ± 0.43 mg/L, p = 0.083). No difference in IOP, serum electrolytes, and coagulative parameters other than D-dimer was observed between COVID-19 positive and negative cases. SARS-CoV-2 were negative in the aqueous humor from 14 COVID-19 positive and 8 negative patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">COVID-19 infection surged the onset of AACG in patients at risk. Mental stress, water intake, increased choroidal thickness due to SARS-CoV-2 induced ACE receptor activation, and hyper-coagulation, may contribute to the disease onset. Ocular involvement should not be ignored in both routine and new systemic emergent conditions.</AbstractText><CopyrightInformation>© 2024 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Ocular Diseases, The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yanqian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Ocular Diseases, The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Guoxing</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Ocular Diseases, The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Rongrong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Ocular Diseases, The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shuxia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Ocular Diseases, The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Peijuan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Ocular Diseases, The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaojie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Ocular Diseases, The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Ocular Diseases, The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shaodan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Ocular Diseases, The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Glaucoma Research Institute, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yuanbo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Clinical Research Center for Ocular Diseases, The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Glaucoma Research Institute, Wenzhou Medical University, Wenzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute angle closure glaucoma</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Intraocular pressure</Keyword><Keyword MajorTopicYN="N">Severe acute respiratory syndrome coronavirus disease 2</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39398055</ArticleId><ArticleId IdType="pmc">PMC11470500</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2024.e38404</ArticleId><ArticleId IdType="pii">S2405-8440(24)14435-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harris E. Study: No new SARS-CoV-2 variants in recent outbreak in China. JAMA. 2023;329(10):788.</Citation><ArticleIdList><ArticleId IdType="pubmed">36811933</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallapaty S. China is relaxing its zero-COVID policy - here's what scientists think. Nature. 2022;612(7940):383–384.</Citation><ArticleIdList><ArticleId IdType="pubmed">36481953</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y., Wang L., Feng Z., Xu H., Li F., Shen Y., et al. Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis. Lancet. 2023;401(10377):664–672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9949854</ArticleId><ArticleId IdType="pubmed">36773619</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheema M., Aghazadeh H., Nazarali S., Ting A., Hodge J., McFarlane A., et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19) Can. J. Ophthalmol. 2020;55(4):e125–e129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7124283</ArticleId><ArticleId IdType="pubmed">32284146</ArticleId></ArticleIdList></Reference><Reference><Citation>Colavita F., Lapa D., Carletti F., Lalle E., Bordi L., Marsella P., et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann. Intern. Med. 2020;173(3):242–243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175424</ArticleId><ArticleId IdType="pubmed">32302380</ArticleId></ArticleIdList></Reference><Reference><Citation>Willcox M.D., Walsh K., Nichols J.J., Morgan P.B., Jones L.W. The ocular surface, coronaviruses and COVID-19. Clin. Exp. Optom. 2020;103(4):418–424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272971</ArticleId><ArticleId IdType="pubmed">32406140</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382(18):1708–1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.P.H., Ko C.N., Zheng K., Lai K.H.W., Wong R.L.M., Lee A., et al. COVID-19: update on its ocular involvements, and complications from its treatments and vaccinations. Asia. Pac. J. Ophthalmol (Phila). 2021;10(6):521–529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8673850</ArticleId><ArticleId IdType="pubmed">34839344</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P., Duan F., Luo C., Liu Q., Qu X., Liang L., et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in hubei province, China. JAMA. Ophthalmol. 2020;138(5):575–578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110919</ArticleId><ArticleId IdType="pubmed">32232433</ArticleId></ArticleIdList></Reference><Reference><Citation>Yener A.U. COVID-19 and the eye: ocular manifestations, treatment and protection measures. Ocul. Immunol. Inflamm. 2021;29(6):1225–1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">34648417</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y., Wang K., Zhu Y., Lyu D., Yu Y., Li S., et al. Ocular manifestations in COVID-19 patients: a systematic review and meta-analysis. Travel. Med. Infect. Dis. 2021;44</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8574127</ArticleId><ArticleId IdType="pubmed">34763068</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong J., Chen R., Zhao H., Zhu Y. COVID-19 and ocular complications: a review of ocular manifestations, diagnostic tools, and prevention strategies. Adv. Ophthalmol. Pract. Res. 2023;3(1):33–38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714126</ArticleId><ArticleId IdType="pubmed">36471811</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H., Zhao M., Mo J., Cao X., Chen W., Wang H. The characteristics of acute macular neuroretinopathy following COVID-19 infection. BMC Ophthalmol. 2023;24(1):19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10782751</ArticleId><ArticleId IdType="pubmed">38200478</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y.Y., Kim J.T., Chang Y.S., Lee M.W., Lee S.C. Increased incidence and diverse manifestations of multiple evanescent white dot syndrome during the COVID-19 pandemic. Sci. Rep. 2024;14(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11139874</ArticleId><ArticleId IdType="pubmed">38816508</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurung H., Kharel Sitaula R., Karki P., Lamichhane G., Singh S., Shrestha E., et al. Seasonal hyperacute panuveitis (SHAPU) outbreak amidst COVID-19 pandemic. Ocul. Immunol. Inflamm. 2023;12:1–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">37699175</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini C., Donati S., Premi E., Baj A., Siracusa C., Genoni A., et al. SARS-CoV-2 on ocular surfaces in a cohort of patients with COVID-19 from the lombardy region, Italy. JAMA. Ophthalmol. 2021;139(9):956–963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934077</ArticleId><ArticleId IdType="pubmed">33662099</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying Y., Zhai R., Sun Y., Sheng Q., Fan X., Kong X. The occurrence of acute primary angle closure triggered, aggravated, and accelerated by COVID-19 infection: retrospective observational study. Front. Public Health. 2023;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10461000</ArticleId><ArticleId IdType="pubmed">37645709</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.T., Chen Z.D., Bing Y.C., Yang Y.F., Zhang Y.N., Yang W.X., et al. vol. 10. 2023. pp. 838–845. (Clinical Presentation of Acute Primary Angle-Closure Glaucoma during the 2019-nCoV Epidemic of Omicron Variants: a Single-Center Retrospective Study).</Citation><ArticleIdList><ArticleId IdType="pubmed">37648680</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z., Yang K., Lv K., Ma Y., Hou X., Liang Y., et al. Increased incidence of acute primary angle closure during the COVID-19 outbreak in China: a retrospective analysis. Medicine (Baltim.) 2024 May 3;103(18)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11062731</ArticleId><ArticleId IdType="pubmed">38701285</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Dai Y., Sun X., Fang Y. The outbreak of acute primary angle-closure cases during the COVID-19 Omicron variant pandemic at a tertiary eye center in Shanghai. Clin. Ophthalmol. 2023 Dec 27;17:4009–4019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10757803</ArticleId><ArticleId IdType="pubmed">38162694</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Namaeh M. Ocular manifestations of COVID-19. Ther. Adv. Ophthalmol. 2022;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9008819</ArticleId><ArticleId IdType="pubmed">35434520</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltsev D.S., Kulikov A.N., Burnasheva M.A., Chhablani J. Photoreceptor outer segment layer thinning as a biomarker in acute central serous chorioretinopathy. Ther. Adv. Ophthalmol. 2023;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10034278</ArticleId><ArticleId IdType="pubmed">36970709</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen H.N., Vannella K.M., Wang Y., Chung J.Y., Kodati S., Ramelli S.C., et al. Histopathology and SARS-CoV-2 cellular localization in eye tissues of COVID-19 autopsies. Am. J. Pathol. 2023;193(11):1809–1816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10032059</ArticleId><ArticleId IdType="pubmed">36963628</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo E.H., Eghrari A.O., Dzhaber D., Shah A., Fout E., Dubovy S., et al. Presence of SARS-CoV-2 viral RNA in aqueous humor of asymptomatic individuals. Am. J. Ophthalmol. 2021;230:151–155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132502</ArticleId><ArticleId IdType="pubmed">34022227</ArticleId></ArticleIdList></Reference><Reference><Citation>Had M., Khilnani K., Vyas N., Chouhan J.K., Dharawat K.S., Bhandari S., et al. Evaluating the presence of SARS-CoV-2 in the intraocular fluid of COVID-19 patients. Indian J. Ophthalmol. 2021;69(9):2503–2506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8544035</ArticleId><ArticleId IdType="pubmed">34427253</ArticleId></ArticleIdList></Reference><Reference><Citation>List W., Regitnig R., Kashofer K., Gorkiewicz G., Zacharias M., Wedrich A., et al. Occurrence of SARS-CoV-2 in the intraocular milieu. Exp. Eye Res. 2020;201</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521885</ArticleId><ArticleId IdType="pubmed">32991885</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts H.W., Akram H., Myerscough J. Negative polymerase chain reaction for SARS-CoV-2 in aqueous sample of patient with confirmed SARS-CoV-2 and recurrence of herpetic stromal keratitis. J. Cataract Refract. Surg. 2020;46(12):e61–e63.</Citation><ArticleIdList><ArticleId IdType="pubmed">33149041</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjay S., Anandula V.R., Mahendradas P., Kawali A., Shetty R. Severe acute respiratory syndrome Corona virus and intraocular fluid sampling. Indian J. Ophthalmol. 2021;69(12):3791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8837366</ArticleId><ArticleId IdType="pubmed">34827057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamalipour A., Ashraf M.A., Moghimi S., Moattari A., Ashra M.J., Abbasi F., et al. Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in the human eye. Ocul. Immunol. Inflamm. 2023;31(1):32–38.</Citation><ArticleIdList><ArticleId IdType="pubmed">34637665</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Li J., Li S., Xu Z., Ma W., Wu X., et al. Presence of CoV-2 antibody in vitreous humor after Cov-2 infection. Heliyon. 2024;10(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11137404</ArticleId><ArticleId IdType="pubmed">38818183</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Q., Fu M., Wang J., Zhao S., Wang H. Potential immune-inflammatory proteome biomarkers for guiding the treatment of patients with primary acute angle-closure glaucoma caused by COVID-19. J. Proteome Res. 2024;23(7):2587–2597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11232099</ArticleId><ArticleId IdType="pubmed">38836775</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Penninger J.M., Li Y., Zhong N., Slutsk A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079879</ArticleId><ArticleId IdType="pubmed">32125455</ArticleId></ArticleIdList></Reference><Reference><Citation>Luhtala S., Vaajanen A., Oksala O., Valjakka J., Vapaatalo H. Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues. J. Ocul. Pharmacol. Ther. 2009;25(1):23–28.</Citation><ArticleIdList><ArticleId IdType="pubmed">19232015</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunzel S.E., Burgel T., Kunzel S.H., Pohlmann D., Zeitz O., Joussen A., et al. Low vulnerability of the posterior eye segment to SARS-COV-2 infection: chorioretinal SARS-CoV-2 vulnerability. Retina. 2022;42(2):236–243.</Citation><ArticleIdList><ArticleId IdType="pubmed">35050927</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D., Zhan Z., Wang B., Liu T., Yu M., Lan Y., et al. Expression of the SARS-CoV-2 receptor ACE2 and protease TMPRSS2 in ocular hypertension eyes of nonhuman primate and human. Curr. Eye Res. 2024;49(3):270–279.</Citation><ArticleIdList><ArticleId IdType="pubmed">38212998</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundogan M., Vural E., Bayram N., AltuneL O., Gundogan F., Goktas S. Change in retinal vessel diameter and choroidal thickness in patients with severe COVID-19: change in Retinal Parameters in Patients with Severe COVID-19. Photodiagnosis Photodyn. Ther. 2022;37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8645280</ArticleId><ArticleId IdType="pubmed">34879296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.S., Liu D.T., Tham C.C., Li R.T., Lam D.S. Epidemiology of acute primary angle-closure glaucoma in the Hong Kong Chinese population: prospective study. Hong. Kong. Med. J. 2001;7(2):118–123.</Citation><ArticleIdList><ArticleId IdType="pubmed">11514744</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudkin A.K., Gray T.L., Awadalla M., Craig J.E. Bilateral simultaneous acute angle closure glaucoma precipitated by non-prescription cold and flu medication. Emerg. Med. Australas. 2010;22(5):477–479.</Citation><ArticleIdList><ArticleId IdType="pubmed">21040488</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi X.L., Li X.X., Liang M.X. Acute angle-closure glaucoma in COVID-19 patients may be precipitated by nonprescription oral cold and flu medication: a literature review. Asian J. Surg. 2024;47(3):1540–1541.</Citation><ArticleIdList><ArticleId IdType="pubmed">38057224</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.W., Lee J.E., Choi H.Y., Lee J.S. Oseltamivir (Tamiflu)-induced bilateral acute angle closure glaucoma and transient myopia. Indian J. Ophthalmol. 2014;62:1165–1167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313501</ArticleId><ArticleId IdType="pubmed">23571265</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng R., Li Y.P., Chen C.L., Huang Y.Q., Lian H., Hu Y.Z., et al. Non-prescription cold and flu medication-induced transient myopia with uveal effusion: case report. BMC Ophthalmol. 2019;19(1):136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6595694</ArticleId><ArticleId IdType="pubmed">31242876</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora K.S., Jefferys J.L., Maul E.A., Quigley H.A. Choroidal thickness change after water drinking is greater in angle closure than in open angle eyes. Invest. Ophthalmol. Vis. Sci. 2012;53(10):6393–6402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6715336</ArticleId><ArticleId IdType="pubmed">22918644</ArticleId></ArticleIdList></Reference><Reference><Citation>Nongpiur M.E., Foo V.H., de Leon J.M., Baskaran M., Tun T.A., Husain R., et al. Evaluation of choroidal thickness, intraocular pressure, and serum osmolality after the water drinking test in eyes with primary angle closure. Invest. Ophthalmol. Vis. Sci. 2015;56(4):2135–2143.</Citation><ArticleIdList><ArticleId IdType="pubmed">25744978</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall B.J., Li G., Chen W., Shelley D., Tang W. Prevalence of depression, anxiety, and suicidal ideation during the Shanghai 2022 Lockdown: a cross-sectional study. J. Affect. Disord. 2023;330:283–290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9972774</ArticleId><ArticleId IdType="pubmed">36863472</ArticleId></ArticleIdList></Reference><Reference><Citation>Piggott B., Chivers P., Sarasjarvi K.K., Bhoyroo R., Lambert M., Millar L., et al. Life in a time of COVID: retrospective examination of the association between physical activity and mental well-being in western Australians during and after lockdown. BMC Publ. Health. 2023;23(1):701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10103040</ArticleId><ArticleId IdType="pubmed">37060048</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W., Lin H., Ren Y., Lin H., Liang Y., Chen Y., et al. Mental health and self-management in glaucoma patients during the COVID-19 pandemic: a cross-sectional study in China. BMC Ophthalmol. 2022;22(1):474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9727872</ArticleId><ArticleId IdType="pubmed">36474185</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourfridoni M., Abbasnia S.M., Shafaei F., Razaviyan J., Heidari-Soureshjani R. Fluid and electrolyte disturbances in COVID-19 and their complications. BioMed Res. Int. 2021;2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060100</ArticleId><ArticleId IdType="pubmed">33937408</ArticleId></ArticleIdList></Reference><Reference><Citation>Machiraju P.K., Alex N.M., Safinaaz, Vadamalai V. Hyponatremia in coronavirus disease-19 patients: a retrospective analysis. Can. J. Kidney. Health. Dis. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728781</ArticleId><ArticleId IdType="pubmed">35003754</ArticleId></ArticleIdList></Reference><Reference><Citation>Malandrino D., Berni A., Fibbi B., Borellini B., Cozzi D., Norello D., et al. Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection. J. Endocrinol. Invest. 2023;46(3):577–586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9595583</ArticleId><ArticleId IdType="pubmed">36284058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozmen S., Ozkan Aksoy N., Cakir B., Alagoz G. Eur. J. Ophthalmol.; 2022. Acute Angle-Closure Glaucoma Concurrent with COVID 19 Infection; Case Report. 11206721221113201.</Citation><ArticleIdList><ArticleId IdType="pubmed">35815850</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami M., Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev. Hematol. 2020;13(11):1265–1275.</Citation><ArticleIdList><ArticleId IdType="pubmed">32997543</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan H., Chen H., Liu C., Cheng L., Yan S., Li H., et al. Diagnostic value of D-dimer in COVID-19: a meta-analysis and meta-regression. Clin. Appl. Thromb. Hemost. 2021;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114749</ArticleId><ArticleId IdType="pubmed">33926262</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zhao K., Wei H., Chen W., Wang W., Jia L., et al. Dynamic relationship between D-dimer and COVID-19 severity. Br. J. Haematol. 2020;190(1):e24–e27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276819</ArticleId><ArticleId IdType="pubmed">32420615</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Gao Y., Shao M., Tang B., Cao W., Sun X. Association between coagulation function and patients with primary angle closure glaucoma: a 5-year retrospective case-control study. BMJ Open. 2017;7(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5695472</ArticleId><ArticleId IdType="pubmed">29102986</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>